EP Patent

EP3778868B1 — Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur

Assigned to Uga Biopharma GmbH · Expires 2022-01-26 · 4y expired

What this patent protects

Patent listed against Triferic.

Drugs covered by this patent

Patent Metadata

Patent number
EP3778868B1
Jurisdiction
EP
Classification
—
Expires
2022-01-26
Drug substance claim
No
Drug product claim
No
Assignee
Uga Biopharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.